On Monday, Zura Bio Ltd (NASDAQ: ZURA) opened higher 12.89% from the last session, before settling in for the closing price of $3.57. Price fluctuations for ZURA have ranged from $2.00 to $7.63 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Company’s average yearly earnings per share was noted 77.22% at the time writing. With a float of $34.97 million, this company’s outstanding shares have now reached $43.59 million.
Let’s look at the performance matrix of the company that is accounted for 15 employees. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
Zura Bio Ltd (ZURA) Insider and Institutional Ownership
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Zura Bio Ltd is 47.97%, while institutional ownership is 47.25%. The most recent insider transaction that took place on May 17 ’24, was worth 496,000. In this transaction Director of this company bought 80,000 shares at a rate of $6.20, taking the stock ownership to the 100,000 shares. Before that another transaction happened on Apr 22 ’24, when Company’s See Remarks bought 7,987 for $3.13, making the entire transaction worth $24,999. This insider now owns 7,987 shares in total.
Zura Bio Ltd (ZURA) Latest Financial update
If we go through the results of last quarter, which was made public on 6/30/2024, the company posted -0.18 earnings per share (EPS) for the quarter, besting the agreed prediction (set at -0.25) by 0.07. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.14 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 77.22% per share during the next fiscal year.
Zura Bio Ltd (NASDAQ: ZURA) Trading Performance Indicators
Check out the current performance indicators for Zura Bio Ltd (ZURA). In the past quarter, the stock posted a quick ratio of 12.57.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.51, a number that is poised to hit -0.12 in the next quarter and is forecasted to reach -0.65 in one year’s time.
Technical Analysis of Zura Bio Ltd (ZURA)
Zura Bio Ltd (NASDAQ: ZURA) saw its 5-day average volume 0.31 million, a positive change from its year-to-date volume of 0.28 million. As of the previous 9 days, the stock’s Stochastic %D was 81.74%. Additionally, its Average True Range was 0.28.
During the past 100 days, Zura Bio Ltd’s (ZURA) raw stochastic average was set at 37.13%, which indicates a significant decrease from 82.63% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 68.55% in the past 14 days, which was lower than the 87.33% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $3.59, while its 200-day Moving Average is $3.90. Nevertheless, the first resistance level for the watch stands at $4.29 in the near term. At $4.56, the stock is likely to face the second major resistance level. The third major resistance level sits at $4.90. If the price goes on to break the first support level at $3.69, it is likely to go to the next support level at $3.35. The third support level lies at $3.08 if the price breaches the second support level.
Zura Bio Ltd (NASDAQ: ZURA) Key Stats
There are currently 43,594K shares outstanding in the company with a market cap of 270.86 million. Presently, the company’s annual sales total 0 K according to its annual income of -69,240 K. Last quarter, the company’s sales amounted to 0 K and its income totaled -12,670 K.
